MRI Breast Without and With IV Contrast There is no relevant literature to support the use of MRI breast without and with IV contrast for breast cancer screening in this clinical setting. Transgender Breast Cancer Screening MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI without IV contrast for breast cancer screening in this clinical setting. US Breast There is insufficient evidence to support the use of US for breast cancer screening of average-risk patients with nondense breast tissue [25,29]. Dense breast tissue lowers the sensitivity of mammography and increases breast cancer risk when compared with fatty breasts [25,30]. In patients with dense breasts and no additional risk factors, breast US may be useful as an adjunct to mammography for incremental cancer detection [25,31]; however, the increased risk of a false-positive examination should be considered in the decision [25,32-34]. Digital Breast Tomosynthesis Screening Annual screening with digital mammography or DBT is recommended in this clinical setting as it is for risk- comparable cisgender women with high-risk lesions, such as lobular neoplasia or atypical ductal hyperplasia, beginning at diagnosis but not before 30 years of age [25,35]. Transmasculine patients with a personal history of breast cancer are recommended to have mammography every 12 months because their breast cancer risk is similar to cisgender women [25,35]. Mammography Screening Annual screening with digital mammography or DBT is recommended in this clinical setting as it is for risk- comparable cisgender women with high-risk lesions, such as lobular neoplasia or atypical ductal hyperplasia, beginning at diagnosis but not before 30 years of age [25,35]. Transmasculine patients with a personal history of breast cancer are recommended to have mammography every 12 months because their breast cancer risk is similar to cisgender women [25,35].
Transgender Breast Cancer Screening. MRI Breast Without and With IV Contrast There is no relevant literature to support the use of MRI breast without and with IV contrast for breast cancer screening in this clinical setting. Transgender Breast Cancer Screening MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI without IV contrast for breast cancer screening in this clinical setting. US Breast There is insufficient evidence to support the use of US for breast cancer screening of average-risk patients with nondense breast tissue [25,29]. Dense breast tissue lowers the sensitivity of mammography and increases breast cancer risk when compared with fatty breasts [25,30]. In patients with dense breasts and no additional risk factors, breast US may be useful as an adjunct to mammography for incremental cancer detection [25,31]; however, the increased risk of a false-positive examination should be considered in the decision [25,32-34]. Digital Breast Tomosynthesis Screening Annual screening with digital mammography or DBT is recommended in this clinical setting as it is for risk- comparable cisgender women with high-risk lesions, such as lobular neoplasia or atypical ductal hyperplasia, beginning at diagnosis but not before 30 years of age [25,35]. Transmasculine patients with a personal history of breast cancer are recommended to have mammography every 12 months because their breast cancer risk is similar to cisgender women [25,35]. Mammography Screening Annual screening with digital mammography or DBT is recommended in this clinical setting as it is for risk- comparable cisgender women with high-risk lesions, such as lobular neoplasia or atypical ductal hyperplasia, beginning at diagnosis but not before 30 years of age [25,35]. Transmasculine patients with a personal history of breast cancer are recommended to have mammography every 12 months because their breast cancer risk is similar to cisgender women [25,35].